MAPTmicrotubule associated protein tau
Autism Reports / Total Reports
5 / 5Rare Variants / Common Variants
2 / 1Aliases
MAPT, DDPAC, FTDP-17L, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, tau-40, MAPTAssociated Syndromes
-Chromosome Band
17q21.31Associated Disorders
-Relevance to Autism
An intronic SNP in the MAPT gene (rs141455452) was found to be significantly associated with ASD (P-value 9.0E-07) in a genome-wide association meta-analysis of 18,381 ASD cases and 27,969 controls from iPSYCH and the Psychiatric Genomic Consortium (PGC) in Grove et al., 2019. A transcriptome-wide association study (TWAS) of 7,805 ASD proband-parent trios, which was subsequently replicated using 35,740 independent samples, using eQTL and splicing quantitative trait loci in 12 brain tissues from GTEx and the CommonMind Consortium (CMC) in Huang et al., 2021 identified MAPT as a gene whose transcriptome-wide association with ASD remained significant after a stringent Bonferroni correction for all genes and all tissues in the analysis (meta-analysis P-value 5.67E-09 in CMC DLPFC-splicing tissue).
Molecular Function
This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
External Links
SFARI Genomic Platforms
Reports related to MAPT (5 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Primary | Identification of common genetic risk variants for autism spectrum disorder | Grove J , et al. (2019) | Yes | - |
2 | Support | - | Huang K et al. (2021) | Yes | - |
3 | Support | - | Rosenthal SB et al. (2021) | Yes | - |
4 | Support | - | Cirnigliaro M et al. (2023) | Yes | - |
5 | Support | - | Soo-Whee Kim et al. (2024) | Yes | - |
Rare Variants (2)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.445G>A | p.Ala149Thr | missense_variant | De novo | - | - | 39334436 | Soo-Whee Kim et al. (2024) | |
c.1342C>T | p.Arg448Ter | stop_gained | Familial | Maternal | Multiplex | 37506195 | Cirnigliaro M et al. (2023) |
Common Variants (1)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Paternal Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.-17-20604T>G;c.-170-19888T>G | - | intron_variant | - | - | - | 30804558 | Grove J , et al. (2019) |
SFARI Gene score
Suggestive Evidence


Score Delta: Score remained at 3
criteria met
See SFARI Gene'scoring criteriaThe literature is replete with relatively small studies of candidate genes, using either common or rare variant approaches, which do not reach the criteria set out for categories 1 and 2. Genes that had two such lines of supporting evidence were placed in category 3, and those with one line of evidence were placed in category 4. Some additional lines of "accessory evidence" (indicated as "acc" in the score cards) could also boost a gene from category 4 to 3.
4/1/2022

Increased from to 3
Krishnan Probability Score
Score 0.75841324445215
Ranking 31/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 4.6826496228243E-5
Ranking 13488/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.63537540354752
Ranking 836/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.43525299142093
Ranking 1076/20870 scored genes
[Show Scoring Methodology]